Literature DB >> 34687544

CAD-RADS may underestimate coronary plaque progression as detected by serial CT angiography.

Bálint Szilveszter1, Borbála Vattay1, Melinda Bossoussou1, Milán Vecsey-Nagy1, Judit Simon1, Béla Merkely1, Pál Maurovich-Horvat1,2, Márton Kolossváry1.   

Abstract

AIMS: We wished to assess whether different clinical definitions of coronary artery disease (CAD) [segment stenosis and involvement score (SSS, SIS), Coronary Artery Disease-Reporting and Data System (CAD-RADS)] affect which patients are considered to progress and which risk factors affect progression. METHODS AND
RESULTS: We enrolled 115 subsequent patients (60.1 ± 9.6 years, 27% female) who underwent serial coronary computed tomography angiography (CTA) imaging with >1year between the two examinations. CAD was described using SSS, SIS, and CAD-RADS. Linear mixed models were used to investigate the effects of risk factors on the overall amount of CAD and the effect on annual progression rate of different definitions. Coronary plaque burdens were SSS 4.63 ± 4.06 vs. 5.67 ± 5.10, P < 0.001; SIS 3.43 ± 2.53 vs. 3.89 ± 2.65, P < 0.001; CAD-RADS 0:8.7% vs. 0.0% 1:44.3% vs. 40.9%, 2:34.8% vs. 40.9%, 3:7.0% vs. 9.6% 4:3.5% vs. 6.1% 5:1.7% vs. 2.6%, P < 0.001, at baseline and follow-up, respectively. Overall, 53.0%, 29.6%, and 28.7% of patients progressed over time based on SSS, SIS, and CAD-RADS, respectively. Of the patients who progressed based on SSS, only 54% showed changes in CAD-RADS. Smoking and diabetes increased the annual progression rate of SSS by 0.37/year and 0.38/year, respectively (both P < 0.05). Furthermore, each year increase in age raised SSS by 0.12 [confidence interval (CI) 0.05-0.20, P = 0.001] and SIS 0.10 (CI 0.06-0.15, P < 0.001), while female sex was associated with 2.86 lower SSS (CI -4.52 to -1.20, P < 0.001) and 1.68 SIS values (CI -2.65 to -0.77, P = 0.001).
CONCLUSION: CAD-RADS could not capture the progression of CAD in almost half of patients with serial CTA. Differences in CAD definitions may lead to significant differences in patients who are considered to progress, and which risk factors are considered to influence progression.
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  CT angiography; coronary artery disease; coronary plaque progression

Mesh:

Year:  2022        PMID: 34687544     DOI: 10.1093/ehjci/jeab215

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   9.130


  2 in total

Review 1.  Multimodality Imaging in Ischemic Chronic Cardiomyopathy.

Authors:  Giuseppe Muscogiuri; Marco Guglielmo; Alessandra Serra; Marco Gatti; Valentina Volpato; Uwe Joseph Schoepf; Luca Saba; Riccardo Cau; Riccardo Faletti; Liam J McGill; Carlo Nicola De Cecco; Gianluca Pontone; Serena Dell'Aversana; Sandro Sironi
Journal:  J Imaging       Date:  2022-02-01

2.  First in-human quantitative plaque characterization with ultra-high resolution coronary photon-counting CT angiography.

Authors:  Victor Mergen; Matthias Eberhard; Robert Manka; André Euler; Hatem Alkadhi
Journal:  Front Cardiovasc Med       Date:  2022-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.